NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EnPlusOne Biosciences

EnPlusOne Biosciences

Private
Watertown, MassachusettsHealthcare & Life Scienceshttps://enplusone.bio/

Last Round

VC Round

Feb 19, 2025

Total Funding Raised

$12M

Company Overview

EnPlusOne Biosciences is a biotechnology company that developed ezRNA™, an enzymatic-based RNA synthesis platform designed to manufacture RNA oligonucleotides for therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Pharma Supply Chain, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

enzymatic RNA synthesisRNA manufacturingRNA synthesis platformRNA oligonucleotidestherapeutic RNAcustom RNA synthesisRNA CDMOmodified RNAsiRNAguide RNAgRNAantisense oligonucleotidesASOtemplate-free synthesisengineered enzymesgreen chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EnPlusOne Biosciences Comps

Public and private peers based on sector, stage, and business model.

EnPlusOne Biosciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EnPlusOne Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 19, 2025
SeedSep 30, 2022

EnPlusOne Biosciences Investors

Notable investors and investment history

EnPlusOne Biosciences investors
InvestorRounds
Northpond VenturesVC Round, Seed
Breakout VenturesSeed, VC Round
Coatue ManagementSeed

EnPlusOne Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EnPlusOne Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EnPlusOne Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts
Year Founded2022
Last FundingFeb 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.